|
Volumn 31, Issue 7 SUPPL. 1, 1999, Pages 64-66
|
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: An interim report
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
TACROLIMUS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TOLERABILITY;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
AZATHIOPRINE;
BLOOD PRESSURE;
CHOLESTEROL;
CREATININE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INSULIN;
KIDNEY TRANSPLANTATION;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID;
RISK FACTORS;
SURVIVAL RATE;
TACROLIMUS;
TRIGLYCERIDES;
|
EID: 0032745319
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(99)00798-8 Document Type: Conference Paper |
Times cited : (35)
|
References (8)
|